DE602005005064D1 - Neue 4-benzylidenpiperidinderivate - Google Patents

Neue 4-benzylidenpiperidinderivate

Info

Publication number: DE602005005064D1
Authority: DE; Germany
Prior art keywords: benzylidenepiperidine; derivatives; new; benzylidenepiperidine derivatives
Prior art date: 2004-07-29
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE602005005064T

Other languages

English (en)

Other versions

DE602005005064T2 (de

Inventor

Istvan Borza

Csilla Horvath

Sandor Farkas

Istvan Gyertyan

Jozsef Nagy

Sandor Kolok

Kornel Galgoczy

Katalin Saghy

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Richter Gedeon Vegyeszeti Gyar Nyrt

Original Assignee

Richter Gedeon Vegyeszeti Gyar RT

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-07-29

Filing date

2005-07-21

Publication date

2008-04-10

2005-07-21 Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT

2008-04-10 Publication of DE602005005064D1 publication Critical patent/DE602005005064D1/de

2009-02-26 Application granted granted Critical

2009-02-26 Publication of DE602005005064T2 publication Critical patent/DE602005005064T2/de

2025-07-22 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Pulmonology (AREA)
Virology (AREA)
Psychology (AREA)
Diabetes (AREA)
AIDS & HIV (AREA)
Hematology (AREA)
Communicable Diseases (AREA)
Molecular Biology (AREA)
Hospice & Palliative Care (AREA)
Tropical Medicine & Parasitology (AREA)
Obesity (AREA)
Oncology (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DE602005005064T 2004-07-29 2005-07-21 Neue 4-benzylidenpiperidinderivate Expired - Lifetime DE602005005064T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
HU0401522		2004-07-29
HU0401522A HUP0401522A2 (en)	2004-07-29	2004-07-29	New 4-benzylidene-piperidine derivatives, pharmaceutical compositions containing the same and process for their preparation
PCT/HU2005/000077 WO2006010964A1 (en)	2004-07-29	2005-07-21	New 4-benzylidene-piperidin derivatives

Publications (2)

Publication Number	Publication Date
DE602005005064D1 true DE602005005064D1 (de)	2008-04-10
DE602005005064T2 DE602005005064T2 (de)	2009-02-26

Family

ID=89985407

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE602005005064T Expired - Lifetime DE602005005064T2 (de)	2004-07-29	2005-07-21	Neue 4-benzylidenpiperidinderivate

Country Status (31)

Country	Link
US (1)	US8008326B2 (de)
EP (1)	EP1773810B1 (de)
JP (1)	JP4814880B2 (de)
KR (1)	KR20070058428A (de)
CN (1)	CN1989128A (de)
AP (1)	AP2074A (de)
AT (1)	ATE387440T1 (de)
AU (1)	AU2005266159B2 (de)
BR (1)	BRPI0513902A (de)
CA (1)	CA2574148A1 (de)
CY (1)	CY1107368T1 (de)
DE (1)	DE602005005064T2 (de)
DK (1)	DK1773810T3 (de)
EA (1)	EA011241B1 (de)
ES (1)	ES2302214T3 (de)
GE (1)	GEP20084492B (de)
HR (1)	HRP20080127T3 (de)
HU (1)	HUP0401522A2 (de)
IL (1)	IL179484A0 (de)
MA (1)	MA28816B1 (de)
MX (1)	MX2007001055A (de)
NO (1)	NO20071108L (de)
NZ (1)	NZ552137A (de)
PL (1)	PL1773810T3 (de)
PT (1)	PT1773810E (de)
RS (1)	RS50573B (de)
SI (1)	SI1773810T1 (de)
TN (1)	TNSN07018A1 (de)
UA (1)	UA87862C2 (de)
WO (1)	WO2006010964A1 (de)
ZA (1)	ZA200700320B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007099828A1 (ja)	2006-02-23	2007-09-07	Shionogi & Co., Ltd.	環式基で置換された含窒素複素環誘導体
CN101426381A (zh) *	2006-04-21	2009-05-06	西诺米克斯公司	含有高效鲜味调料的可食用组合物及其制备方法
WO2007146550A2 (en) *	2006-06-08	2007-12-21	Bristol-Myers Squibb Company	Alkene piperidine derivatives as antiviral agents
CA2730253A1 (en) *	2008-07-08	2010-01-14	Alphonso Higuera	Novel crystalline form of 2-[4-(4-fluoro-benzyl)-piperidine-1-yl]-2-oxo-n-(2-oxo-2,3-dihydro-benzoxazol-6-yl)-acetamide
CN102762554A (zh)	2010-02-16	2012-10-31	辉瑞大药厂	5-ht4受体的部分激动剂(r)-4-((4-((4-(四氢呋喃-3-基氧基)苯并[d]异*唑-3-基氧基)甲基)哌啶-1-基)甲基)四氢-2h-吡喃-4-醇
AU2011299904A1 (en)	2010-09-07	2013-05-02	Taiho Pharmaceutical Co., Ltd.	Prostaglandin D synthase inhibitory piperidine compounds
US20120322824A1 (en) *	2011-01-04	2012-12-20	Surratt Christopher K	Cocaine Antagonist/Antidepressant Pharmaceutical Preparations
ES2627541T3 (es)	2012-04-20	2017-07-28	Ucb Pharma, S.A.	Métodos para tratar la enfermedad de Parkinson
CN107108601B (zh)	2014-08-28	2021-08-20	阿森纽荣股份公司	糖苷酶抑制剂
DK3389658T3 (da)	2015-12-18	2021-01-11	Merck Sharp & Dohme	Glycosidasehæmmere og anvendelser deraf
AU2017222958B2 (en)	2016-02-25	2019-07-18	Asceneuron S. A.	Glycosidase inhibitors
US11261183B2 (en)	2016-02-25	2022-03-01	Asceneuron Sa	Sulfoximine glycosidase inhibitors
KR20180132626A (ko)	2016-02-25	2018-12-12	아셰뉴론 에스아	글리코시다제 저해제
KR102800480B1 (ko)	2016-02-25	2025-04-25	아셰뉴론 에스아	피페라진 유도체의 산 부가 염
US9486444B1 (en)	2016-03-21	2016-11-08	King Saud University	Anti-cancer compound
US11213525B2 (en)	2017-08-24	2022-01-04	Asceneuron Sa	Linear glycosidase inhibitors
US12016852B2 (en)	2018-08-22	2024-06-25	Asceneuron Sa	Pyrrolidine glycosidase inhibitors
CA3110032A1 (en)	2018-08-22	2020-02-27	Asceneuron S.A.	Succinate and fumarate acid addition salts of piperazine derivatives
WO2020039028A1 (en)	2018-08-22	2020-02-27	Asceneuron S. A.	Tetrahydro-benzoazepine glycosidase inhibitors
WO2020039029A1 (en)	2018-08-22	2020-02-27	Asceneuron S. A.	Spiro compounds as glycosidase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA9610738B (en) *	1995-12-22	1997-06-24	Warner Lambert Co	Subtype selective nmda receptor ligands and the use thereof
TW498067B (en) *	1996-07-19	2002-08-11	Hoffmann La Roche	4-hydroxy-piperidine derivatives
CA2220649C (en) *	1996-12-03	2007-02-13	F. Hoffmann-La Roche Ag	4-hydroxy-piperidine derivatives
KR100890676B1 (ko) *	2001-07-24	2009-03-26	리히데 게데온 베기에스제티 기아르 알티	신규한 카르복시산 아미드 화합물

2004
- 2004-07-29 HU HU0401522A patent/HUP0401522A2/hu unknown
2005
- 2005-07-21 MX MX2007001055A patent/MX2007001055A/es active IP Right Grant
- 2005-07-21 ES ES05763197T patent/ES2302214T3/es not_active Expired - Lifetime
- 2005-07-21 JP JP2007523160A patent/JP4814880B2/ja not_active Expired - Fee Related
- 2005-07-21 US US11/658,789 patent/US8008326B2/en not_active Expired - Fee Related
- 2005-07-21 EP EP05763197A patent/EP1773810B1/de not_active Expired - Lifetime
- 2005-07-21 WO PCT/HU2005/000077 patent/WO2006010964A1/en active Application Filing
- 2005-07-21 EA EA200700367A patent/EA011241B1/ru not_active IP Right Cessation
- 2005-07-21 GE GEAP20059892A patent/GEP20084492B/en unknown
- 2005-07-21 HR HR20080127T patent/HRP20080127T3/xx unknown
- 2005-07-21 DE DE602005005064T patent/DE602005005064T2/de not_active Expired - Lifetime
- 2005-07-21 AT AT05763197T patent/ATE387440T1/de active
- 2005-07-21 BR BRPI0513902-3A patent/BRPI0513902A/pt not_active IP Right Cessation
- 2005-07-21 PT PT05763197T patent/PT1773810E/pt unknown
- 2005-07-21 PL PL05763197T patent/PL1773810T3/pl unknown
- 2005-07-21 SI SI200530213T patent/SI1773810T1/sl unknown
- 2005-07-21 CN CNA2005800243746A patent/CN1989128A/zh active Pending
- 2005-07-21 KR KR1020077000262A patent/KR20070058428A/ko not_active Ceased
- 2005-07-21 AP AP2006003839A patent/AP2074A/en active
- 2005-07-21 CA CA002574148A patent/CA2574148A1/en not_active Abandoned
- 2005-07-21 AU AU2005266159A patent/AU2005266159B2/en not_active Ceased
- 2005-07-21 RS RSP-2008/0123A patent/RS50573B/sr unknown
- 2005-07-21 DK DK05763197T patent/DK1773810T3/da active
- 2005-07-21 UA UAA200702171A patent/UA87862C2/ru unknown
- 2005-07-21 NZ NZ552137A patent/NZ552137A/xx not_active IP Right Cessation
2006
- 2006-11-22 IL IL179484A patent/IL179484A0/en unknown
2007
- 2007-01-11 ZA ZA200700320A patent/ZA200700320B/en unknown
- 2007-01-17 TN TNP2007000018A patent/TNSN07018A1/en unknown
- 2007-02-22 MA MA29703A patent/MA28816B1/fr unknown
- 2007-02-27 NO NO20071108A patent/NO20071108L/no not_active Application Discontinuation
2008
- 2008-03-27 CY CY20081100349T patent/CY1107368T1/el unknown

Also Published As

Publication number	Publication date
MA28816B1 (fr)	2007-08-01
ATE387440T1 (de)	2008-03-15
HK1105966A1 (en)	2008-02-29
NO20071108L (no)	2007-02-27
HUP0401522A2 (en)	2006-04-28
EA011241B1 (ru)	2009-02-27
ES2302214T3 (es)	2008-07-01
CY1107368T1 (el)	2012-12-19
SI1773810T1 (sl)	2008-06-30
IL179484A0 (en)	2007-05-15
EA200700367A1 (ru)	2007-06-29
ZA200700320B (en)	2008-05-28
NZ552137A (en)	2009-08-28
MX2007001055A (es)	2007-04-16
RS50573B (sr)	2010-05-07
DK1773810T3 (da)	2008-06-23
AU2005266159A1 (en)	2006-02-02
EP1773810A1 (de)	2007-04-18
GEP20084492B (en)	2008-09-25
BRPI0513902A (pt)	2008-05-20
DE602005005064T2 (de)	2009-02-26
AU2005266159B2 (en)	2011-09-29
US20080312222A1 (en)	2008-12-18
AP2006003839A0 (en)	2006-12-31
EP1773810B1 (de)	2008-02-27
WO2006010964A1 (en)	2006-02-02
CA2574148A1 (en)	2006-02-02
JP2008508247A (ja)	2008-03-21
TNSN07018A1 (en)	2008-06-02
AP2074A (en)	2009-12-14
HU0401522D0 (en)	2004-09-28
PT1773810E (pt)	2008-04-09
UA87862C2 (en)	2009-08-25
JP4814880B2 (ja)	2011-11-16
PL1773810T3 (pl)	2008-07-31
CN1989128A (zh)	2007-06-27
HRP20080127T3 (hr)	2008-04-30
KR20070058428A (ko)	2007-06-08
US8008326B2 (en)	2011-08-30

Publication	Publication Date	Title
IS8578A (is)	2006-12-08	3- karbamoýl - 2- pýridón afleiður
EP1790650A4 (de)	2009-12-30	Neue substituierte imidazolderivate
DK1725553T3 (da)	2008-08-18	Tetrahydropyridoindolderivater
EP1778298A4 (de)	2010-03-31	Lipoprotein-nanoplattformen
DK1761541T3 (da)	2008-04-28	Pyrrazolo-pyrimidin-derivater
ATE540935T1 (de)	2012-01-15	Chinazolinderivate
ATE553079T1 (de)	2012-04-15	Heteroarylphenylharnstoffderivat
DE602005022258D1 (de)	2010-08-26	Perfluoroelastomere
DE602005006955D1 (de)	2008-07-03	Klopferkennung
ATE417830T1 (de)	2009-01-15	Sulfonylbenzimidazolderivate
ATE387440T1 (de)	2008-03-15	Neue 4-benzylidenpiperidinderivate
EP1839669A4 (de)	2012-12-12	Neue angiogenesehemmer
ATE425167T1 (de)	2009-03-15	Neue pyridothienopyrimidinderivate
ATE430142T1 (de)	2009-05-15	Phenylpiperazin-methanon-derivate
DE602005023145D1 (de)	2010-10-07	Neue androgene
DE602005004840D1 (de)	2008-04-03	Erntegutabstreifer
EP1774546A4 (de)	2012-11-28	Zündspulanordnung
ATE404542T1 (de)	2008-08-15	4-phenylpyrimidin-2-carbonitrilderivate
DE602005006889D1 (de)	2008-07-03	Fahrzeugluftausströmöffnungsanordnung
DE602005021608D1 (de)	2010-07-15	Plasmaanzeigetafelansteuerverfahren
EP1768619A4 (de)	2009-09-16	Wirbelsäulenorthose
ATE365731T1 (de)	2007-07-15	4-amino-5-cyanopyrimidinderivate
DE502005007584D1 (de)	2009-08-06	Raftfahrzeuge
DE602005008596D1 (de)	2008-09-11	Neue tetracyclische tetrahydrofuranderivate
ATE445604T1 (de)	2009-10-15	Neue 2,6-diaminopyridin-3-on-derivate

Legal Events

Date	Code	Title	Description
2009-04-02	8364	No opposition during term of opposition